Avelox

Avelox

moxifloxacin

Manufacturer:

Bayer HealthCare Pharma

Distributor:

DKSH
Concise Prescribing Info
Contents
Moxifloxacin HCl
Indications/Uses
Treatment of acute exacerbations of chronic bronchitis, community-acquired pneumonia, acute sinusitis, uncomplicated skin & skin structure infections, uncomplicated pelvic inflammatory disease (ie, female upper genital tract infections including salpingitis & endometritis), complicated skin & skin structure infections (including diabetic foot infections), complicated intraabdominal infections including polymicrobial infections eg, abscesses.
Dosage/Direction for Use
Adult ≥18 yr 400 mg once daily. Duration of treatment: Acute exacerbation of chronic bronchitis 5 days. Community-acquired pneumonia 10 days. Acute sinusitis, uncomplicated skin & skin structure infections 7 days. Uncomplicated pelvic inflammatory disease 14 days. Complicated skin & skin structure infections total treatment duration for sequential therapy (IV followed by oral therapy) 7-21 days. Complicated intra-abdominal infections total treatment duration for sequential therapy (IV followed by oral therapy) 5-14 days.
Administration
May be taken with or without food: Swallow tab whole.
Contraindications
Hypersensitivity to quinolones. Childn, growing adolescent. Pregnancy, lactation.
Special Precautions
Patients w/ known QT interval prolongation or patients on concomitant medication known to prolong the QTc interval. Uncorrected hypokalemia; ongoing proarrhythmic conditions; seizures, known or suspected CNS disorders which may predispose to seizures or lower the seizure threshold; severe hepatic impairment. Patients on class IA/III antiarrhythmics. Tendon inflammation & rupture may occur. Avoid extensive UV exposure.
Adverse Reactions
Mycotic superinfections, headache, dizziness, QT prolongation, nausea, vomiting, GI & abdominal complaints, diarrhea, increase in transaminases, inj & infusion site reactions.
Drug Interactions
Antacids, minerals, multivit, antiretrovirals (eg, didanosine), sucralfate.
MIMS Class
ATC Classification
J01MA14 - moxifloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Presentation/Packing
Form
Avelox infusion bag 400 mg/250 mL
Packing/Price
1's
Form
Avelox FC tab 400 mg
Packing/Price
5's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in